| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 0.1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |